|
| Lifecycle Phase |
Interrogative |
Measures |
Variables |
Potential Data Sources / AI Search Examples |
|
|
| 1. Conception & Initiation |
What |
Availability of baseline prevalence & mortality datasets; Endgame policy concept papers produced |
% of states with current prevalence data; # of policy concept papers published |
CDC NHIS, BRFSS, STATE System for prevalence; state health dept reports; Surgeon General reports |
|
| How |
Quality of stakeholder engagement processes |
# of stakeholder meetings; % of priority stakeholders engaged |
NAQC quitline annual survey; minutes from state tobacco control coalition meetings |
|
| Where |
Geographic coverage of baseline data |
% of states with reliable baseline prevalence measures |
CDC STATE maps; county-level BRFSS prevalence data |
|
| Who |
Diversity of engaged stakeholder groups |
# of unique stakeholder categories (gov, NGO, research, community) |
NAQC survey partner lists; state tobacco advisory board rosters |
|
| When |
Time from problem identification to initial strategy draft |
Avg. months elapsed |
Legislative records; news archives; HHS press releases |
|
| Why |
Specificity of mission statements |
% of mission statements with measurable targets |
State tobacco control plans; CDC OSH national strategy documents |
|
|
| 2. Policy & System Design |
What |
Completeness of draft legislation & regulatory frameworks |
% of FCTC-recommended measures included; # of policy gaps identified |
CDC STATE System policy coverage; state legislative tracking (NCSL) |
|
| How |
Process adherence to regulatory impact assessment standards |
% of policy drafts with documented impact analysis; review cycle time (days) |
Federal Register entries; GAO reports on tobacco regulation |
|
| Where |
State-level alignment with federal frameworks |
% of states with harmonized endgame policies |
CDC STATE policy alignment datasets |
|
| Who |
Representation in policy design forums |
% of policy design meetings with multi-sector participation |
Legislative hearing transcripts; public comment registries |
|
| When |
Policy drafting cycle time |
Avg. days from drafting start to legislative submission |
Bill histories from Congress.gov and state legislature portals |
|
| Why |
Alignment of policy goals with national health targets |
% of goals tied to Healthy People or FCTC objectives |
State tobacco plans vs Healthy People TU objectives |
|
|
| 3. Implementation & Operation |
What |
Campaign material coverage; Quitline/NRT resource stock |
% of population reached by campaigns; NRT supply adequacy index |
CampaignReach metrics; NAQC Quitline reports; NRT distribution records |
|
| How |
Campaign deployment effectiveness; Compliance inspection coverage |
% of planned campaigns delivered; # of inspections per 1,000 retailers |
FDA Tobacco Compliance Check database; campaign progress reports |
|
| Where |
Geographic reach of campaigns and enforcement |
% of population in covered jurisdictions; inspections per region |
FDA inspection location data + Census population maps |
|
| Who |
Stakeholder participation in campaign delivery |
% of NGOs actively delivering campaign components |
NAQC program participation data |
|
| When |
Campaign and inspection timeliness |
% of activities delivered on schedule |
Campaign schedules; FDA enforcement calendar |
|
| Why |
Alignment of program KPIs to strategic goals |
% of program KPIs mapping to national endgame targets |
State DOH performance plans; CDC OSH performance dashboards |
|
|
| 4. Evaluation & Adaptation |
What |
Timeliness and completeness of surveillance datasets |
Avg. lag (months) between data collection and release; % of data fields complete |
CDC YRBSS, NYTS release calendars; STATE System update logs |
|
| How |
Responsiveness of policy adjustments |
Avg. time from new threat detection to policy update |
FDA guidance issuance timelines; policy change notices |
|
| Where |
Distribution of data collection sites |
% of counties with active surveillance points |
YRBSS site list; state survey sampling frames |
|
| Who |
Multi-stakeholder involvement in evaluation |
% of evaluation panels with non-gov participants |
Panel rosters; evaluation meeting minutes |
|
| When |
Speed of response to emerging threats |
Avg. days to policy update after detection |
DOJ/FDA illicit trade enforcement announcements |
|
| Why |
Use of evaluation findings to adjust goals |
% of updated goals following evaluation cycles |
Revision histories in state tobacco control plans |
|
|
| 5. Consolidation & Endgame Transition |
What |
Endgame law enactment rate; Supply reduction instruments in place |
% of endgame measures legislated; # of retail outlets under supply quotas |
CDC policy tracking; state licensing data |
|
| How |
Execution speed of final cessation pushes |
% of remaining smokers reached with targeted support; weeks to implement supply quota |
State cessation program reports; NRT procurement records |
|
| Where |
Cross-border enforcement coverage |
# of customs checkpoints integrated into enforcement plan |
CBP operation logs; DOJ task force reports |
|
| Who |
Cross-agency coordination effectiveness |
# of joint operations conducted; % of joint objectives met |
MOUs; joint task force meeting reports |
|
| When |
Synchronization of final measures nationally |
% of states implementing endgame measures within target window |
Policy adoption timelines from CDC STATE |
|
| Why |
Goal clarity in final push phase |
% of endgame policies with specific prevalence targets |
Legislative text review; agency strategic plans |
|
|
| 6. Sustainment / Sunset |
What |
Post-endgame monitoring systems operational |
% of illicit trade cases detected vs prosecuted; # of norm reinforcement materials issued/year |
CBP/DOJ enforcement stats; public health education archives |
|
| How |
Continuity of surveillance and education |
% of planned monitoring events completed; % of educational programs renewed annually |
Surveillance schedules; funding renewal records |
|
| Where |
Post-endgame coverage of illicit trade monitoring |
% of high-risk border zones under continuous monitoring |
CBP surveillance maps; enforcement jurisdiction reports |
|
| Who |
Community engagement in sustaining tobacco-free norms |
% of community groups funded for prevention activities |
Grant award databases; program rosters |
|
| When |
Frequency of post-endgame monitoring events |
Avg. interval (months) between surveillance reports |
Report publication dates |
|
| Why |
Maintenance of post-endgame vision |
% of strategic plans including relapse prevention objectives |
Strategic plan review; public health policy archives |
|
